Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating nucleobase concentration (HP:0010932)help
Parent Node:
expand
Abnormal circulating pyrimidine concentration (HP:0004353)help
..Starting node
..expand
Reduced dihydropyrimidine dehydrogenase level (HP:0003654)help
Term ID: 3654
Name: Reduced dihydropyrimidine dehydrogenase level
Synonym: Dihydropyrimidine dehydrogenase deficiency
Definition: An abnormal reduction in dihydropyrimidine dehydrogenase (NADP+) level.
Comments:
Reference: HP:0003654
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandDeficient excision of UV-induced pyrimidine dimers in DNA (HP:0003213) help
..expandobsolete Increased urinary orotic acid concentration (HP:0010928) help
..expandReduced orotidine 5-prime phosphate decarboxylase level (HP:0003267) help
..expandUraciluria (HP:0012127) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003654HP:0003654Reduced dihydropyrimidine dehydrogenase level0DPYD CL E G H18063012OMIM:274270Dihydropyrimidine dehydrogenase deficiency.144
HP:0003654HP:0003654Reduced dihydropyrimidine dehydrogenase level0DPYD CL E G H18063012ORPHA:1675Dihydropyrimidine dehydrogenase deficiencyHP:0040281 - Very frequent144
HP:0003654HP:0003654Reduced dihydropyrimidine dehydrogenase level0DPYS CL E G H18073013OMIM:222748Dihydropyrimidinuria.44


Genes (2) :DPYD DPYS

Diseases (3) :OMIM:274270 ORPHA:1675 OMIM:222748
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.